Headinvest, LLC Merck & Co., Inc. Transaction History

Headinvest, LLC

$525 Million
Q3 2024

A detailed history of Headinvest, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Headinvest, LLC holds 21,855 shares of MRK stock, worth $2.14 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

21,855

Previous 22,265 1.84%

Holding current value

$2.14 Million

Previous $2.76 Million 9.98%

% of portfolio

0.47%

Previous 0.55%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$111.15 - $128.97 $45,571 - $52,877	-410 Reduced 1.84%	21,855 $2.48 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $100,525 - $107,963	-812 Reduced 3.52%	22,265 $2.76 Million
Q1 2024 Aug 14, 2024	SELL	$113.24 - $131.95 $275,173 - $320,638	-2,430 Reduced 9.53%	23,077 $3.05 Million
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $55,199 - $60,070	-551 Reduced 2.11%	25,507 $2.78 Million
Q3 2023 Dec 11, 2023	SELL	$102.95 - $114.33 $19,148 - $21,265	-186 Reduced 0.71%	26,058 $2.68 Million
Q2 2023 Aug 23, 2023	SELL	$108.61 - $118.38 $146,406 - $159,576	-1,348 Reduced 4.89%	26,244 $3.03 Million
Q1 2023 May 17, 2023	BUY	$102.94 - $114.86 $56,514 - $63,058	549 Added 2.03%	27,592 $2.94 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $32,702 - $41,929	-374 Reduced 1.36%	27,043 $3 Million
Q3 2022 Dec 28, 2022	SELL	$84.53 - $94.96 $33,812 - $37,984	-400 Reduced 1.44%	27,417 $2.36 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $45,919 - $52,052	550 Added 2.02%	27,817 $2.54 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $1,690 - $1,895	23 Added 0.08%	27,267 $2.24 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $7,878 - $9,868	-109 Reduced 0.4%	27,244 $2.09 Million
Q3 2021 Nov 16, 2021	SELL	$71.68 - $78.83 $12,042 - $13,243	-168 Reduced 0.61%	27,353 $2.05 Million
Q2 2021 Aug 30, 2021	BUY	$70.31 - $77.77 $12,866 - $14,231	183 Added 0.67%	27,521 $2.14 Million
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $1.47 Million - $1.73 Million	-21,328 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $381,026 - $422,861	5,309 Added 24.89%	26,637 $2.18 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $381,026 - $422,861	-5,309 Reduced 19.93%	21,328 $1.77 Million
Q3 2020 Nov 24, 2020	BUY	$73.18 - $82.95 $74,643 - $84,609	1,020 Added 5.02%	21,328 $1.77 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $26,970 - $30,689	383 Added 1.92%	20,308 $1.57 Million
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $348,860 - $483,536	-5,506 Reduced 21.65%	19,925 $1.53 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $410,129 - $568,458	6,473 Added 34.14%	25,431 $1.87 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $548,335 - $618,732	-7,068 Reduced 27.16%	18,958 $1.72 Million
Q3 2019 Nov 21, 2019	BUY	$76.08 - $82.93 $65,428 - $71,319	860 Added 3.42%	26,026 $2.19 Million
Q2 2019 Aug 22, 2019	SELL	$69.84 - $81.59 $18,507 - $21,621	-265 Reduced 1.04%	25,166 $2.11 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $1.75 Million - $2 Million	-25,140 Reduced 49.71%	25,431 $2.12 Million
Q4 2018 Feb 22, 2019	BUY	$65.24 - $75.71 $1.63 Million - $1.89 Million	24,986 Added 97.66%	50,571 $3.86 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $7,268 - $8,547	126 Added 0.49%	25,585 $1.82 Million
Q2 2018 Aug 09, 2018	SELL	$50.83 - $59.72 $18,349 - $21,558	-361 Reduced 1.4%	25,459 $1.55 Million
Q1 2018 Apr 09, 2018	SELL	$50.96 - $59.23 $5,350 - $6,219	-105 Reduced 0.41%	25,820 $1.41 Million
Q4 2017 Jan 30, 2018	SELL	$51.62 - $61.64 $19,357 - $23,115	-375 Reduced 1.43%	25,925 $1.46 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $1.54 Million - $1.66 Million	26,300	26,300 $1.45 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.

Account